USDA approves drug for canine allergic and atopic dermatitisJanuary 6, 2026Befrena (tirnovetmab), an anti–IL-31 monoclonal antibody injection for the treatment of canine allergic and atopic dermatitis, is intended for use in dogs of any age and is recommended at dosing intervals of six to eight weeks following treatment.
SPONSORED CONTENTHill's Prescription Diet Metabolic Weight + j/dNutrition clinically shown to improve cats’ mobility in as little as 1 month and stimulate metabolism to help burn fat and lose weight. + Learn More